AI assistant
Sending…
REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2012
Aug 27, 2012
29977_dirs_2012-08-27_0e3f2887-5b94-4aff-a94b-17fe54a9a94d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REGENERON PHARMACEUTICALS INC (REGN)
CIK: 0000872589
Period of Report: 2012-08-23
Reporting Person: ROBERTS WILLIAM (VP Regulatory Development and)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-08-23 | Common Stock | S | 15000.0 | $144.0 | Disposed | 46144.0 | Direct |
| 2012-08-24 | Common Stock | G | 3500.0 | $0.0 | Disposed | 42644.0 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1200.0 | Indirect |
| Common Stock | 4331.0 | Indirect |
| Common Stock | 1200.0 | Indirect |
Footnotes
F1: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2: Gift of Common Stock to charitable organization.
More from REGENERON PHARMACEUTICALS, INC.
Regulatory Filings
2026
May 8
Major Shareholding Notification
2026
Apr 30
Interim / Quarterly Report
2026
Apr 29
Earnings Release
2026
Apr 29
Annual Report
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Earnings Release
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3